Publications by authors named "Steven Mortillo"

Claim this Profile
E
Erratum. The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure.
Samira Fargali, Angelo L Garcia, Masato Sadahiro, Cheng Jiang, William G Janssen, Steven Mortillo

FASEB J· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure.
Samira Fargali, Angelo L Garcia, Masato Sadahiro, Cheng Jiang, William G Janssen, Steven Mortillo

FASEB J· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function.
José L Moreno, Carolina Muguruza, Adrienne Umali, Steven Mortillo, Terrell Holloway

J Biol Chem· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compensatory redistribution of neuroligins and N-cadherin following deletion of synaptic β1-integrin.
Steven Mortillo, Alice Elste, Yongchao Ge, Shekhar B Patil, Kuangfu Hsiao

J Comp Neurol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinases.
Rajeev S Bhide, Louis J Lombardo, John T Hunt, Zhen-Wei Cai, Joel C Barrish, Steven Mortillo

Mol Cancer Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor.
Réjean Ruel, Carl Thibeault, Alexandre L'Heureux, Alain Martel, Zhen-Wei Cai, Steven Mortillo

Bioorg Med Chem Lett· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based VEGFR-2 kinase inhibitors.
Zhen-Wei Cai, Donna Wei, Robert M Borzilleri, Ligang Qian, Amrita Kamath, Steven Mortillo

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.
Rajeev S Bhide, Zhen-Wei Cai, Yong-Zheng Zhang, Ligang Qian, Donna Wei, Steven Mortillo

J Med Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.
Robert M Borzilleri, Zhen-Wei Cai, Christopher Ellis, Joseph Fargnoli, Aberra Fura, Steven Mortillo

Bioorg Med Chem Lett· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the pyrrolo[2,1-f][1,2,4]triazine nucleus as a new kinase inhibitor template.
John T Hunt, Toomas Mitt, Robert Borzilleri, Johnni Gullo-Brown, Joseph Fargnoli, Steven Mortillo

J Med Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis